BMJ1d
Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen
Correspondence to Dr Claudia Diana Wurster, Department of Neurology, Ulm University, Ulm 89081, Germany; claudia.wurster{at}uni-ulm.de Spinal muscular atrophy (SMA) is a monogenetic motoneuron disease ...
BMJ1d
Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome
OBJECTIVES To examine the proportions of type 1 and type 2 muscle fibres and the degree of muscle fibre atrophy and hypertrophy in patients with chronic fatigue syndrome in relation to lactate ...
BMJ1d
Multiple cavernous haemangioma showing marked calcification on cranial radiography
Correspondence to: Dr N Hagiwara, Third Department of Medicine, Shinshu University, Asahi 3–1–1, Matsumoto, Nagano, 390–8621, Japan; n-hagi{at}hsp.md.shinshu-u ...
BMJ4d
Retinitis pigmentosa prior to familial ALS caused by a homozygous cilia and flagella-associated protein 410 mutation
Correspondence to Dr Takashi Kurashige, Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure 737-0023, Japan; takashi-kurashige{at}hiroshima-u.ac.jp ...
BMJ6d
In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
Introduction Associations between cerebral small vessel disease (SVD) and inflammation have been largely examined using peripheral blood markers of inflammation, with few studies measuring ...
BMJ7d
Management of patients with generalised myasthenia gravis and COVID-19: four case reports
Correspondence to Dr Annemarie Hübers, University Hospitals Geneva Department of Clinical Neurosciences, Geneve 1211, Switzerland; annemarie.hubers{at}hcuge.ch Myasthenia gravis (MG) is an autoimmune ...
BMJ7d
Neuroplasticity and aphasia treatments: new approaches for an old problem
Given the profound impact of language impairment after stroke (aphasia), neuroplasticity research is garnering considerable attention as means for eventually improving aphasia treatments and how they ...
BMJ8d
Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?
OBJECTIVES To investigate the prevalence of changes in mood, personality, and behaviour in frontotemporal dementia (FTD) and Alzheimer's disease (AD) and hence, which features reliably distinguish ...
BMJ9d
The cholinergic hypothesis of Alzheimer’s disease: a review of progress
Dr Paul T Francis, Dementia Research Laboratory, Division of Biomolecular Sciences, Guy’s, King’s and St Thomas’ Schools of Biomedical Sciences, King’s College, St Thomas Street, London SE1 9RT, UK.
BMJ10d
Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era
Adult-onset leukodystrophies and genetic leukoencephalopathies comprise a diverse group of neurodegenerative disorders of white matter with a wide age of onset and phenotypic spectrum. Patients with ...
BMJ12d
Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia
1 Department of Neurorehabilitation, IRCCS Don C Gnocchi Foundation, University of Milan, Italy 2 Department of Neurology, IRCCS S Raffaele, Milan, Italy 3 Department of Neurology, Ospedali Riuniti, ...
BMJ21d
Code intracerebral haemorrhage: reorganising stroke care for intracerebral haemorrhage
Non-traumatic intracerebral haemorrhage (ICH) remains a high mortality and morbidity disease with few single intervention clinical trials demonstrating improvements in functional outcome. The failure ...